A case report highlights the pathogen’s potential to cause severe, devastating ocular infections, despite aggressive treatment
Articles
The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy
The company, which has European headquarters in Basel, Switzerland, plans to use the funds for a non-interventional, observational study and a first-in-human clinical trial
Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.
The laser integrates into the Corneal Refractive Workflow alongside the Visumax 800 and SMILE pro software
The commercialisation agreements for the biosimilar to aflibercept (Eylea) cover Israel, major parts of Europe and the Asia-Pacific Region
The launch follows a CE Mark received in late 2024
The study built on previous research indicating specific retinal variables can serve as disease-related biomarkers in neurodegenerative diseases
The authors investigated systemic adverse events associated with commercial mydriatics administered during retinopathy of prematurity (ROP) screening
ViGeneron, based in Munich, also received approval for dose escalation in the ongoing phase 1b clinical trial
Clinicians need to better understand how to reduce the growth of antibiotic-resistant, more virulent bacteria, the authors said
Investigators reported that the trial demonstrated significant improvements in visual function and retinal structure for patients with optic neuritis
In October, Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for treatment of diabetic macular oedema
Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer
The RESTORE Study is the follow-up study of the RESCUE and REVERSE studies of lenadogene nolparvovec to treat vision loss from LHON
Investigators emphasised the need for continued efforts to raise awareness and support patients in attending regular screening
Hot topics around the globe, from clinical trials to the solar eclipse
Highlights from the year, courtesy of our colleagues at Ophthalmology Times
Alcon Laboratories is voluntarily recalling one lot (Lot 10101) of its Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count, after identifying fungal contamination in a sealed vial.
The top therapeutic advancements in myopia, diabetes, dry eye and more
Trending topics and milestone stories from our year in ophthalmology
Finnish researchers report on registry data and changing workload resulting from anti-VEGF therapies
The number of patients with retinal vascular diseases is expected to increase over time due to the aging population and lifestyle changes
Our top 10 print stories highlight the core content concepts we explored this year
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the vision-threatening condition
Low-level light therapy for dry eye disease and chalazion
The timeline demonstrates international innovation and collaboration
Sophisticated programmes require an evolving mindset
Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology
Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)
The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)
Advertisement
Advertisement
